We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Videos

Video

CappBravo Single Channel Pipette

Video

Contract Assay Services at STEMCELL Technologies Inc.

Video

A Microfluidic Toolbox for Nucleic Acid Based Diagnostic Tests

As many biodetection assays, especially nucleic-acid based tests, require a more or less complex sample preparation protocol, microfluidics is seen as one of the key enabling technologies to realize the integration of these sample prep protocols with the detection scheme on a single device.
Video

Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward

This presentation will cover how bottlenecks in the validation of candidate tumour progression-related biomarkers can be overcome.
Video

Next-generation POC Devices for Western and Global Health Markets

Samuel Sia, Columbia University, speaking at Point of Care Diagnostics 2015
Video

Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer

Despite extensive research effort there are no accepted clinical biomarkers that predict for response to systemic combination chemotherapy in advanced CRC.
Video

Spread Plate machine Rosie - AAA Lab Equipment - Automation for labs in food and water

Video

SPR Imaging-based Microarray for Enhanced Multianalyte Detection in Blood Plasma

Marketa Bockova, Institute of Photonics and Electronics ASCR, speaking at Biodetection & Biosensors 2015
Video

"Lab-in-a-hanky" - What Comes Next after Lab-on-a-Chip

In this talk, Dr Frank Bier discusses next generation biosensors including Point-of-care Diagnostics testing (POCT) and where it might go.
Video

Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

This talk will illustrate, with case studies, how appropriate and timely use of imaging biomarkers can significantly reduce the risk, cost and time of drug development.
Advertisement